≡ Menu

Latest News & Blog

Source: John Hopkins Magazine Fall 2016

jhm-fall-2016-class-notes

 

This coming October I’m honored to direct the most attended cardiology meeting in Arizona again which is being held at the Arizona Biltmore Hotel in Phoenix, Oct. 13 and 14, 2016. The two-day continuing education conference will center on recent advancements and controversial topics in multiple areas of cardiovascular disease, and present new ideas for tailoring the most appropriate treatment plan for each individual.

Focus will be placed on gauging and monitoring therapy, including recognizing symptoms, evaluating risk factors, guiding treatment through imaging, general and functional testing, and appropriate therapy. Unlike most programs, this will be delivered as a case-based approach with case examples that will make the lectures more relevant to everyday practitioners.

This symposium is designed for primary care physicians, clinical cardiologists, interventional cardiologists, cardiovascular surgeons, basic scientists, vascular medicine specialists, nurses, perfusionists, cath lab technicians, and other health care professionals with a special interest in the field of cardiovascular medicine. Presentations this year will also be relevant to practitioners involved with foot care.

Promedica International designates this live activity for a maximum of 12.5 hours AMA PRA Category 1 Credit(s)™.  CME certificates will be sent in a secure document via email upon completion of the online evaluation form post symposium.

We have several new additions to this year’s symposium sessions, including:

  • Continuing Nursing Education symposium designed with an emphasis on providing the best in patient care. This symposium will take place on Wednesday, October 12 from noon – 5 p.m., at the Arizona Biltmore. To register for the Nursing Symposium, click here.
  • Registered attendees of the CDM symposium are also welcome to attend the satellite symposium, Optimizing Treatment and Improving Care Transitions in Chronic Heart Failure, on Thursday, Oct. 13, from 6:45-7:45 a.m. When registering for the main scientific sessions, guests will have the option to register for this additional course at no additional fee.

If you are interested in registering to attend the main symposium and/or nursing symposium, click here.

Dr. Richard Heuser receives health care leadership award from AZ Business Magazine. Read full article here.

heuser-cardiology-innovation-award-phoenix-heart-center

Dr. Richard Heuser, chief of cardiology at St. Luke’s Medical Center and Phoenix Heart Center was given the Top Cardiovascular Innovation Award from the Cardiovascular Research Technologies for Medical Innovation.

Heuser also is founder of Arizona Medical Systems, which developed a new technology called the Punctual Guidewire, which has been issued three patents from the U.S. Patent and Trademark Office and has been used in a pre-clinical study.

The device allows cardiologists to use a tiny needle to access arteries and veins, helping interventional cardiologists and other vascular specialists eliminate steps in their procedures.

The device is expected to have a tremendous effect in more than 13 million cardiology procedures in the United States.

“The Punctual Guidewire is a simple yet novel idea that serves a unique purpose, flipping the dichotomy of requiring a larger needle to introduce a larger wire, to allowing a far smaller needle for the same large diameter wire,” Heuser said.

richard-heuser-award-winning-cardiologist-phoenix-azDr. Richard Heuser, chief of cardiology at St. Luke’s Medical Center and Phoenix Heart Center, was given the Top Cardiovascular Innovation Award.

Read the full story via Phoenix Business Journal.

 

Congratulations to Richard Heuser, MD, who was named 2016 Physician of the Year at the 2016 Healthcare Leadership Awards, which honors the most innovative healthcare leaders in the state.

heuser

Richard Heuser, MD, chief of cardiology, St. Luke’s Medical Center and Phoenix Heart Center. Heuser is an internationally-recognized cardiologist, inventor, educator, author and one of the early pioneers of the angioplasty procedure.

richard-heuser-phoenix-cardiology-cardiologist-in-phoenix-arizona

This past February, Dr. Richard Heuser of Phoenix Heart Center presented during the Innovation session of the 2016 Cardiovascular Technology Conference (CRT2016).

Dr. Heuser spoke on Introduction of the Punctual Guidewire for Arterial and Venous Access, which won the Top Cardiovascular Innovation Award.

Read more about the technology here.

(Pictured above: Dr. Heuser with Ron Waksman, Director of the meeting)

Author: Richard R. Heuser, M.D., FACC, FACP, FESC, FSCAI

You probably know that hypertension (high blood pressure) can increase the risk of heart disease and stroke. But did you know that one in four adults in the U.S. has high blood pressure? Considering that many adults are unaware of their condition, it’s no wonder that hypertension is often referred to as “the silent killer.” Fortunately, new hypertension treatments are on the horizon.

Renal Denervation

Many patients with hypertension are already taking prescription medication for their blood pressure and other conditions. When at all possible, I support treating patients without the use of medication, as patients can enjoy a higher quality of life and, in some cases, a better outcome. A new treatment for high blood pressure known as “renal denervation” (RDN) now puts that goal within reach.

With RDN, patients receive local anesthesia. A small device is threaded through the arteries to the kidneys, guided by x-ray images. Once the device reaches the kidneys, high frequency signals are used to “burn” high activity nerves. This opens up blood flow to the kidneys, reducing hypertension and, therefore, the risk of heart disease and stroke.

Currently, there are at least five renal denervation catheter systems with CE Mark approval. This means that renal denervation is still a relatively new hypertension treatment that is not widely available. However, renal denervation is expected to become more widely used as a treatment modality for high blood pressure in the near future.

ROX Coupler Placement

Another new hypertension treatment option is the ROX Coupler placement. This device, once implanted, reroutes blood from an artery to a vein in the upper thigh, resulting in a lowering of blood pressure. The minimally invasive procedure is catheter-based and performed under general anesthesia.

The ROX Coupler placement opens up the possibility of living without hypertension medications, something many patients who have undergone the procedure would never have dreamed of before.

Are you at risk for high blood pressure? Use our self-assessment tool to find out. Call Phoenix Heart Center at 602-234-0004 for more information.
Please consult with your physician before undertaking any form of medical treatment or adopting any exercise program or dietary guidelines.

Author: Richard R. Heuser, M.D., FACC, FACP, FESC, FSCAI

Over the last few years, the field of interventional cardiology has witnessed some amazing new developments. These developments are radically affecting patients’ quality of life, raising the bar for health care everywhere.

One of these developments, in particular, really excites me. It’s a special outpatient procedure known as “Radial First same-day Percutaneous Coronary Intervention (PCI).” The procedure is a new alternative method to traditional angiograms. In order to better answer your questions about this new interventional cardiology procedure, I’ll first explain some terms.

Defining the Terms

  • Radial First describes the method of the procedure. A small, flexible catheter is inserted into the radial artery, which travels through the forearm.
  • Percutaneous simply means “through the skin.”
  • Coronary Intervention (also known as a coronary angiogram or cardiac catheterization) refers to the type of procedure. In this procedure, which is used to evaluate the health of the heart, a catheter is threaded through the blood vessels until it reaches the heart. A special contrast dye is then injected through the catheter. X-ray imaging picks up on the contrast dye and reveals arterial blockages.

How long will I be hospitalized for a Radial First PCI procedure?

One of the major benefits of this procedure is that it is performed on an outpatient basis. Patients are mobile almost immediately following the procedure and can go home just a few hours later.

 How many surgeons perform this kind of percutaneous coronary intervention?

Very few. Currently, this technology is in great demand but low supply. Only about 2 percent of interventional cardiologists offer Radial First PCI.

Besides going home soon, what are the patient benefits of Radial First?

Radial First offers an 80 percent reduction in patient bleeding (compared to the femoral approach). Plus, early research has found a significant reduction in major adverse cardiac events for up to one year after surgery.

Where can I have a Radial First PCI in Arizona?

St. Luke’s Medical Center pioneered Arizona’s first Radial First program. I’m proud to be associated with a hospital that is leading the way in interventional cardiology.

For more information about Radial First PCI, you can call Phoenix Heart Center at 602-234-0004. This procedure is performed at St. Luke’s Medical Center in Tempe, AZ.
Please consult with your physician before undertaking any form of medical treatment or adopting any exercise program or dietary guidelines.

Connect

Contact Us

Have questions? Need to schedule your
appointment? Contact us, today!

Contact Us

Menu Title